Join this dot, Unlikely to met high 30 day endpoint set so trial would only need to enroll 240 patients, powered study.
Your trying to infer that the product was futile by using the word futile in your posts probably in self delusion that by doing so you'll be able to mislead enough shareholders into selling so as to drop share price so your short position turns positive for you!
Self delusion. Your fooling no one!!
Unlikely to meet high 43% benefit over control group, so 42% is possible outcome so is 41%, 40%,39%,38%,37% and so on and on and on!
So how is your short position going to look should a significant result still be achieved that FDA approves EUA.
A lot of pressure in US hospital system at present and they now have a President who is eager to get hands on and have positive influence.
https://hotcopper.com.au/posts/50397812/single
COVID-19 USA Daily Numbers, page-356
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |